RGX-121 has received Orphan Drug Product, Rare Pediatric Disease, Fast Track and Regenerative ... of cognitive deficits that otherwise occurs in MPS I patients. Positive interim data from a ...
The Government will do whatever it takes to protect our nation’s farmers from the risk posed by foot and mouth disease.” ...
She warned that an outbreak of ASF or FMD could cause 'irreparable damage' to the pig industry, leading to the loss of export markets worth around £600m annually. It would also trigger regional ...
13d
ABP Live on MSNRare Disease Day 2025: Raising Awareness On Stem Cell BreakthroughsRare Disease Day, observed on February 28th, aims to raise awareness about rare diseases and the challenges faced by patients ...
Regenxbio closes strategic partnership with Nippon Shinyaku for MPS diseases: Rockville, Maryland Wednesday, March 5, 2025, 14:00 Hrs [IST] Regenxbio Inc., a leading clinical-stag ...
REGENXBIO Inc. (Nasdaq: RGNX) today announced the closing of its previously announced strategic partnership with Nippon Shinyaku.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results